Welcome to the official website of COST Action TD1206 "StanDerm"

About the Action


Action Chair

Prof. Swen Malte John
Institute for interdisciplinary Dermatological Prevention
and Rehabiliation,
University of Osnabrück, Department of Dermatology,
Environmental Medicine and Health Theory
Sedanstr. 115
49090 Osnabrück, Germany
Fax: (0049) (0) 541 969 2445
Phone: (0049) (0) 541 969 2624
sjohn(at) | 

Action Vice Chair

Dr. Sanja Kezic
Academic Medical Center
Meibergdreef 15
1100 AZ Amsterdam, Netherlands
Phone: (0031) (020) 566 5321

Action Science Officer

Dr. Giuseppe Lugano
COST Office
Avenue Louise 149
1050 Brussels, Belgium
Fax: 0032 (0) 2 533 38 90
Phone: 0032 (0) 2 533 38 22

Find the relevant COST Office website describing the Action.

Our funding is through COST (European Cooperation in Science and Technology)


Upcoming StanDerm WG Summit and Workshop

06 June 2016 | Time to take stock

The next StanDerm workshop will take place from 12-13 October in Krakow, Poland. A working group summit, carried out on Day 1, will focus on important research issues of the working groups. At the end of Day 1  a core group meeting will be held to discuss StanDerm's final workshop 2017 in Berlin. At the workshop on Day 2 keynote speakers shall address selected topics important to the field of improved prevention and patient management in OSD.

ESCD 2016

30 May 2016 | Congress of the European Society of Contact Dermatitis 14-17 Sept. in Manchester (UK)

The 13 th Congress of the European Society of Contact Dermatitis (ESCD) will take place in Manchester 14 – 17 September 2016.  The meeting starts with a one day presymposium on occupational skin disease. The scientific programme is now complete and full details can be found on the ESCD2016 website. There are a limited number of late breaking abstract spaces available in the Hot Topics session please click on the right hand link for details. There is a course on Saturday 17th targeted specifically at nurses and trainees. If you have not yet already done so please do not forget to register for the Congress.  Please do so before the *30 th June* to take advantage of the early bird rate at


Sign the Global Call to Action

22 April 2016 | Protect outdoor workers from UV radiation caused by the sun.

On 20 April 2016, a Global Call to Action was launched by the European Academy of Dermatology and Venereology (EADV) to urge policy makers, employers' and workers' organisations, and physicians to protect Europe's outdoor workers from skin cancer caused by solar UV-radiation.  The Call to Action entails six main actions to ensure a better protection of outdoor workers. As underlined by Prof. Swen Malte John, chair of our StanDerm Action and chair of the EADV Media & PR Committee, during a 2-hour policy debate at the European Parliament, there are easy, simple and cheap solutions to avoid this preventable type of cancer. Currently, however, there is no EU-wide requirement to protect workers at risk. That´s why the EADV is asking everybody to support the call to action to raise awareness of the dangers of non-melanoma skin cancer for Europe's outdoor workers.  Add your name to the list and send a clear message to policy makers that they also need to take action now and protect Europe's outdoor workers.  Click here to sign. 


Training School Occupational Skin Cancer

18 April 2016 | Registration closed

With over 25 applications for StanDerms' 3rd Training School  from 15 countries, the course is now fully booked and registration closed. 

Non-melanoma Skin Cancer by Solar UV

04 April 2016 | New report published on the neglected occupational threat for almost 14.5. million European workers.

There are almost 14.5 million workers in Europe, who spend at least 75% of their working time under the sun. StanDerm members, in collaboration with the European Academy of Dermatology and Venereology (EADV), recently published a new report which clearly shows that this major part of Europe’s workforce is under an increased risk of developing non-melanoma skin cancer (NMSC). The report entitled “Non-melanoma Skin Cancer by Solar UV. The Neglected Occupational Threat”, provides an overview and highlights new research on the current European status quo regarding epidemiology, risk assessment and UVR exposure measurement, legal management and health care services provided to affected workers. In a consensus report found in the same publication, the experts call European member states to recognise NMSC as an occupational disease and the EU Commission to revise the 2006 Directive on Artificial Optical Radiation (2006/25EC) to include solar UV radiation within its scope. The Directive currently completely excludes sunlight exposure of worker. "Prevention is simple and cheap, and skin cancer is one of the few cancers entirely curable if detected early," comments Prof. Dr. Swen Malte John, one of the editors of the report, and Action Chair of StanDerm. 


Training School Occupational Skin Cancer

03 February 2016 | Call for the upcoming TS in Modena, Italy, 5-7 September 2016.

StanDerms' 3rd Training School addresses all MDs, PhD students, early postdocs and young professionals from related fields interested in improving skills in prvention, diagnosis and treatment of Occupational Skin Cancers (OSCs). The event will be organized by the Chair of Dermatology and the Chair of Occupational Medicine of the University of Modena and Reggio Emilia, Italy. The aim of this international, multi-disciplinary course is to combine theoretical perspectives with practical up-to-date information on solar radiation exposure, new therapeutic perspectives of OSC treatment as well  as its legal recognition and prevention in Europe. 
Registration deadline: 15 April.  

Better regulation and transparency

10 December 2015 | StanDerm expresses concerns about EU Commission publication

In response  to an image used by the European Commission in a recent publication on Better regulation and transparency”

StanDerm sent a letter to the European Commissioner for Employment, Social Affairs, Skills and Labour Mobility, Mrs. Marianne Thyssen to convey its support with the concerns expressed by  Coiffure EU and UNI Europa and the European Association of Dermatology and Venereology (EADV)  about this taunting image. The Commission openly mocks the ongoing efforts of social partners to implement a European Framework Agreement on health and safety in the hairdressing sector signed in April 2012, under the presence of the then Commissioner of Employment, Social Affairs and Inclusion Laszlo Andor. WHO and ILO, together with the EADV regarded it a major European breakthrough in safety and health since it is an autonomous initiative on the part of the workers and employers of the hairdressing sector. 

© European Commission

New Action member

07 December 2015 | Montenegro joining StanDerm

 A warm welcome to Dr Natasa Vukotic-Djuricanin and Dr Milena Djurovic as new members of our Action.  Both are working as dermatologists at the Dermato-Venereological Clinic of the Clinical Center of Montenegro in Podgorica since over 15 years. This is the 17th inclusiveness target country joining StanDerm, comprising now a total of 31 countries represented in this Action. 

WHO Call to Action

02 December 2015 | Sign the call to protect health from climate change.

The WHO is keen to promote health as a key focus at the Climate Change Summit held from 30 November 60 11 December 2015 in Paris. It therefore issued a call to join WHO Call to Action to protect health from climate change. As dermatologists, this is our chance to raise the importance of ultraviolet light and skin cancer. The Action chair, encourages all StanDerm members to consider signing this call to action on behalf of their organisations to highlight the importance of dermatological health to this important movement. 

Moving Ahead - Vision.Human.Work

23 November 2015 | 4th International Strategy Conference 21-24 March 2016 in Dresden, Germany.

The 4th International Strategy Conference on Safety and Health at Work (ISC2016) will be taking a closer look at the top trends in what is currently being discussed in occupational safety and health. International and national experts are invited to join the conference between 21 and 24 March 2016 in Dresden, Germany to network and exchange their views on the future of prevention. The Action chair will be a key note speaker on occupational skin cancer.  

Working Group meetings in 2016

16 November 2015 | Update of meeting calendar.

With the start of 2016, each StanDerm working group (WG 1 - WG 5) will hold their annual meeting. For more details about the meeting date and venue, please click the respective working group and go to agenda.

Croatian Congress on Occupational Health

26 October 2015 | StanDerm's vice-chair represented the Action in Sibenik.

At the 6th Croatian Congress  on Occupational Health (30 September - 4 October 2015), StanDerm was presented by its vice-chair Dr. Sanja Kezic with a plenary lecture entitled „Science as a base - Occupational skin diseases: current research and prevention activities in Europe“Dr. Kezic focused on the recent advances in the field of OSD aetiology including the role of individual risk factors. Furthermore, she summarized the results of current prevention acitivites in Europe.   The lecture was held on the first day of the Congress, together with presentations of WHO-SEENWH, ICOH, and European Association of Schools of Occupational Medicine (EASOM) representatives. Dr. Kezic´s presentation raised great interest among participants.  At the request of participants, handouts are now available on the official website of the Croatian Society on Occupational HealthAn abstract of the presentation is published in the Congress Book of abstracts.     

Classification of MCIT/MIT

05 October 2015 | StanDerm submitted statement to the CLH public consultation.

On 26 August, StanDerm submitted a statement to the CLH public consultation related to the proposed classification of MCIT/MIT.  After having considered the report for 2-methylisothiazol-3(2H)-one (MIT), StanDerm postulates that the limits for attributing the H317 risk phrase and for labeling MIT should not be higher than the presently recommended maximum use concentrations for rinse-off cosmetics (see SCCS/1521/13). Based on extensive clinical experience, the proposed threshold concentration of 0.06% is definitely not low enough to protect workers and consumers from skin sensitization.

StanDerm impacts on the relevance of preventing occupational skin diseases in Norway

16 September 2015 | Online media presentation on 15 October.

Our member Jose Hernan Alfonso is bringing occupational skin diseases to the forefront of dermatology and media in Norway. On 15 October, he will give a presentation on epidemiology of work-related skin diseases in an open conference organized by the National Institute of Occupational Health of Norway. The conference will also be transmitted live online

Slovakia joining StanDerm

14 September 2015 | StanDerm continues to attract countries from the Eastern part of Europe.

Slovakia's application as new member of StanDerm is already underway and we look forward to welcoming Dr. Slavomir URBANCEK as respresenative at the Management Committee (MC) very soon. The next MC meeting will be held on the occasion of the StandDerm Workshop in Copenhagen (6 October 2015).

Short-term Scientific Mission (STSM)

01 July 2015 | Call launched for 3rd grant year.

The 3rd grant year (1 June 2015 – 31 May 2016) has been approved. Therefore, the next Call for short-term scientific missions (STSM) is now launched.  Note that all interested STSM applicants must be engaged in an official research programme as a PhD Student or postdoctoral fellow or can be employed by, or affiliated to, an Institution or legal entity which has within its remit a clear association with performing research.  

Upcoming StanDerm WG Summit and Workshop

02 June 2015 | StanDerm´s lifecycle is halfway through: time for a review.

The next StanDerm workshop will take place from 5-6 October in Copenhagen, Denmark prior to the EADV congress.  A working group summit, carried out on Day 1, will focus on important research issues of the working groups. At the workshop on Day 2 keynote speakers shall address selected topics of strong relevance to the field of occupational dermatoses.

Skin cancer induced by natural UV radiation: Discussions led in Brussels

22 May 2015 | StanDerm representatives are once again ensuring that the right strategies for the prevention of OSD are clearly heard in Brussels.

StanDerm´s chair, Swen Malte John, together with other StanDerm representatives, EADV President Erwin Tschachler and WHO representative Emilie Van Deventer  met with Stefaan Hermans,  Head of Cabinet of the Commissioner of EU-DG EMPL on 19 May 2015 to discuss inter alia  the Directive 2006/25/EC dealing with the minimum health and safety requirements regarding the exposure of workers to risks arising from physical agents, namely artificial optical radiation. The possible need for revision and improvement of the Directive to include risks and prevention measures related to solar sources affecting outdoor workers was the focus of discussion.  Sun exposure at workplaces is a highly relevant and at the same time almost neglected occupational health hazard, leading to Non-melanoma Skin Cancer (NMSC).  Recent large-scale meta-analyses have demonstrated that outdoor workers are at least at a 43% higher risk for basalioma, and an almost doubled risk for squamous cell carcinoma.  However, to date, most countries have not incorporated UV-induced occupational NMSC in their national occupational diseases lists. Hence, specific work protection laws with set exposure limits have to include solar UV-radiation, and not only, as presently at the EU level, UV-radiation from artificial sources.

Early Stage Researchers Forum

10 March 2015 | Young scientists will present their most recent research findings in Munich.

The Early Stage Researchers Forum, followed by a half-day seminar will be held on 29 July 2015 in Munich at the occasion of the 4th International Summer Academy of Practical Dermatology (ISA 2015). 

Turkey new Action member

05 February 2015 | StanDerm continues to attract countries from the Eastern part of Europe.

In April, Turkey has become new member of StanDerm and is represented by Dr. Mehmet MELIKOGLU, Ataturk University Medical Faculty, Dept. Dermatology in Erzurum, at the Management Committee (MC). 

New Action members

03 November 2014 | StanDerm´s membership is growing: Bosnia and Herzegovina and Slovenia joined our Action.

Two new parties have joined our COST Action StanDerm: Bosnia and Herzegovina and Slovenia. This makes a total of 29 parties represented in StanDerm. 

Argentinean Congress of Dermatology

08 September 2014 | Poster presentation by StanDerm.

The COST Action StanDerm was presented with a poster at the occasion of the XXI Argentinean Congress of Dermatology, 28-31 August 2014, Mendoza, Argentina. 

International Partner Countries

16 June 2014 | Non-COST applications to the Action.

The application of the School of Public Health and Family Medicine from Cape Town University, South Africa, and the application of the Association of Dermatologists in Argentina were approved by COST Brussels office.

StanDerm stands tall for healthy skin at work

17 March 2014 | Taking prevention standards in OSD to the EU level.

On 5 November 2013, StanDerm experts organized a debate with members of the European Parliament from different political parties and European Commission policy officials on the latest research findings and the scientific basis for the prevention of the disease in Brussels. The meeting was attended by representatives from the World Health Organization (WHO), the European Agency for Safety and Health at Work (OSHA), the European Commission and COST office representatives. 



In Europe:

  • occupational skin diseases (OSD) represent up to 30% of occupational diseases
  • OSD related costs exceed 5 billion €/year by loss of productivity
  • there are isolated efforts of OSD prevention in some countries
  • there is no coordinated action between the stakeholders at national and international levels
  • surveillance and diagnostics of OSD are hampered by lack of common monitoring of new allergens  in workplaces. 

The EU Commission therefore defined lacking prevention of OSD a top priority problem.  

"StanDerm" comprises 31 countries and aims at coordinating activities relevant for OSD prevention, including basic sciences (aetiology and individual susceptibility), epidemiological surveillance, transnational and applied clinical research.This involves regulatory issues (e.g. REACH), development of interdisciplinary workers' education concepts, identifying individual susceptibility markers enabling tailored prevention and pre-employment counselling.  

This COST Action will allow setting up transnational controlled intervention studies in large cohorts in high-risk professions. The outcome will be evidence-based common European standards on OSD prevention and patient management. This will provide a safer working environment and targeted early intervention for workers throughout Europe, enhancing economic competitiveness, particularly of small and medium-sized enterprises (SMEs).

Memorandum of Unterstanding (MoU) is signed by the participating governments of the COST countries. The MoU details the content, the arrangement and related activities for the implementation of the Action.